| Name | Title | Contact Details |
|---|
Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.
Abiomed is a manufacturer of medical implant devices, including the AbioCor artificial heart and Impella. It is headquartered in Danvers, Massachusetts and has an additional office in Aachen, Germany. It has 500 employees.
ENOCHS is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
E-T Endodontic Technology Ltd is a Halifax, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Texadent Com is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.